EDITOR'S PAGE
AT
A GLANCE
Atrial fibrillation (AF) is the most common
sustained arrhythmia in the adult population and
the prevalence increases with age. People with
AF have a mortality rate that is twice as high
as that among people with sinus rhythm. Underlying
cardiac disease, hypertension, diabetes, thyrotoxicosis,
and alcohol ingestion in susceptible persons predispose
to the development of atrial fibrillation. However,
17% of patients develop AF without evidence of
risk factors ("lone" AF). Thromboembolism and
stroke are serious complications and hence, the
treatment of AF continues to be a challenge. In
this issue of the Journal, Nattel from The Montreal
Heart Institute Research Center, Canada, (p.152-163)
gives a superb and comprehensive review of the
recent evolution of our understanding of the mechanisms
of atrial fibrillation and discusses scientific
findings challenging the prevailing multiple-circuit
re-entry mechanism. He discusses the potential
implications of this new knowledge for therapeutic
innovation such as catheter-based approaches.
Hopefully, with increased understanding of the
genesis of AF, new drugs and better techniques
can be found for prevention and therapy.
The continuing quest for improvement and refinement
of existing technology as well as their innovative
clinical application has enabled us to treat or
ameliorate life-threatening arrhythmia with ever-increasing
precision. Szili-Torok et al from the Thoraxcentre,
Rotterdam, Netherlands (p.172-176), report their
experience on cryothermal ablation therapy of
a left-sided accessory pathway under guidance
with a 3-dimensional navigational system.
Despite the impressive strides achieved with non-surgical
treatment of coronary artery disease, treatment
of valvular diseases is still very much in the
domain of cardiac surgeons. Mitral valve repair
has proven to be superior over valve replacement
in mitral regurgitation. The results of conventional
surgical mitral valve reconstructions such as
mitral annuloplasty with either a prosthetic ring
or suture plication have been suboptimal in complex
mitral valve lesions. In the early 1990s, Alfieri
and colleagues introduced a simple and effective
surgical technique called "edge-to-edge" mitral
reconstruction for a variety of complex mitral
valve lesions. Alfieri and colleagues from the
San Rafael University Hospital, Milan, Italy (p.164-169),
provides a comprehensive and excellent overview
of their technique, indications, and clinical
experience at their institution. The accompanying
editorial by Kalangos of Geneva, Switzerland,
addresses some of the controversial issues related
to the procedure (p.170-171).
Does the widespread perception that "honey is
good for you" have a scientific basis? The History
of Medicine section traces the use of honey as
medicine from antiquity to the present. Illness
is fundamentally different from disease.
"Illness" refers to the innately human experience
of symptoms and suffering - how the sick person
and the members of his family or a wider social
network perceive, live with, and respond to symptoms
and disability. Illness is the "lived experience"
of monitoring bodily processes such as respiratory
wheezes, cramps, stuffed sinuses, etc. and the
patient’s judgments about how best to cope with
the distress and with the practical problems in
daily living it creates. Behavior during illness
consists in initiating treatment, following the
advice of people and deciding when to seek care
from professionals or alternative practitioners.
The essay, Curing a Cold (p.178-179) is a humorous
illustration of how ordinary people deal with
a familiar malady – the common cold.
Smoking is a major public health problem worldwide.
Active intervention programs to increase public
awareness of the dangers of smoking are needed
to combat the tobacco epidemic. In his Chairman’s
Reflection (p.189-193), Dr. H.A. Hajar Al Binali
narrates his efforts and experience in the fight
against "the evil weed" in Qatar.®
Rachel Hajar, MD

|